Key result
In vitro expression of 13 LMNA variants identified in patients with dilated cardiomyopathy revealed abnormal nuclear morphology and lamin A localization in 10 (77%) variants, supporting their pathogenicity.
Why the study?
Do specific LMNA variants identified in dilated cardiomyopathy patients cause abnormal lamin A localization and nuclear morphology in vitro?
Do specific LMNA variants identified in dilated cardiomyopathy patients cause abnormal lamin A localization and nuclear morphology in vitro?
In vitro morphological analysis supports the pathogenicity of 10 of 13 tested LMNA variants found in dilated cardiomyopathy patients, including some with uncertain or nonsegregation.
May aid LMNA variant reclassification in dilated cardiomyopathy; leaves open clinical adoption pending in vivo or segregation validation.
BACKGROUND: Mutations in the LMNA gene, encoding lamins A/C, represent a significant cause of dilated cardiomyopathy. We recently identified 18 protein-altering LMNA variants in a cohort of 324 unrelated patients with dilated cardiomyopathy. However, at least one family member with dilated cardiomyopathy in each of 6 pedigrees lacked the LMNA mutation (nonsegregation), whereas small sizes of 5 additional families precluded definitive determinations of segregation, raising questions regarding contributions by those variants to disease. METHODS AND RESULTS: We have consequently expressed, in COS7 cells, GFP-prelamin A (GFPLaA) fusion constructs incorporating the 6 variants in pedigrees with nonsegregation (R101P, A318T, R388H, R399C, S437Hfsx1, and R654X), the 4 variants in pedigrees with unknown segregation (R89L, R166P [in 2 families], I210S, R471H), and 3 additional missense variants (R190Q, E203K, and L215P) that segregated with disease. Confocal immunofluorescence microscopy was used to characterize GFP-lamin A localization and nuclear morphology. Abnormal phenotypes were observed for 10 of 13 (77%) variants (R89L, R101P, R166P, R190Q, E203K, I210S, L215P, R388H, S437Hfsx1, and R654X), including 4 of 6 showing nonsegregation and 3 of 4 with uncertain segregation. All 7 variants affecting coil 1B and the lamin A-only mutation, R654X, exhibited membrane-bound GFP-lamin A aggregates and nuclear shape abnormalities. Unexpectedly, R388H largely restricted GFP-lamin A to the cytoplasm. Equally unexpected were unique streaked aggregates with S437Hfsx1 and giant aggregates with both S437Hfsx1 and R654X. CONCLUSIONS: This work expands the recognized spectrum of lamin A localization abnormalities in dilated cardiomyopathy. It also provides evidence supporting pathogenicity of 10 of 13 tested LMNA variants, including some with uncertain or nonsegregation.
No takes yet. Share an insight, caveat, or question.
Cowan et al. (2009) studied Idiopathic or Familial Dilated Cardiomyopathy (n=324). LMNA variants was evaluated on Abnormal phenotypes (GFP-lamin A localization and nuclear morphology). In vitro expression of 13 LMNA variants identified in patients with dilated cardiomyopathy revealed abnormal nuclear morphology and lamin A localization in 10 (77%) variants, supporting their pathogenicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: